This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
Rankings published in 2026
Tier 1
Tier 2
Tier 3
Notable
Tier 1
Tier 2
Tier 3
Tier 4
Notable
Linked Reviews
Financial and corporate
Jia Yuan Law Offices is a PRC law firm headquartered in Beijing with further offices in Shanghai, Shenzhen, Hong Kong, Guangzhou and Xi’an.
Focusses / specialisms
The firm is focussed on capital markets, providing legal services including IPOs in domestic and overseas markets, corporate restructuring and refinancing of listed companies.
Key clients
Key clients include China National Materials Group Corporation, Aviation Industry Corporation of China, China National Salt Industry Corporation, Qingdao Port International, and China International Capital Corporation.
Research period review: 33rd edition (2022/2023)
In 2022, the firm kept busy with equity capital markets work. It advised on Jiangsu Asieris Pharmaceuticals’ listing on SSE STAR Market; private-owned military enterprise Huaqin Technology on its IPO on STAR Market. The Jia Yuan team also assisted Shanghai Junshi Biosciences in completion of its issuance and listing of A-shares to specific investors.
In overseas capital markets, the firm also assisted new energy technology company CALB Group in its H-share listing. In China Tourism Group Duty Free Corporation’s IPO in Hong Kong, the Jia Yuan team represented the sponsors and lead underwriter.
On investment funds side, the firm completed several fund establishment and equity financing transactions last year. The team set up China Venture Capital Beijing Intelligence Fund, which raised Rmb10 billion in late 2022.
On the M&A side, the firm represented China Avionics Systems in its shares exchange to absorb and merge with AVIC Electromechanical Systems. The completion of this merger would make Avionics a world-class aviation airborne company and build an airborne system listing platform with a market value of Rmb100 billion ($14 billion).
Deal highlights: 33rd edition (2022/2023)
Jiangsu Asieris Pharmaceuticals’ IPO on SSE STAR Market.
Huaqin Technology IPO on SSE STAR Market.
AVIC UAV Science and Technology Innovation on SSE STAR Market.
MGI Tech’s IPO on SSE STAR Market.
CALB Group’s Hong Kong IPO.
